Concepedia

Marianne Eybye

ME

Statistics

Publications

10

Citations

450

H-Index

10

Active since

2003

Affiliations

Moderna Therapeutics (United States)(Current)

GlaxoSmithKline (United States)

GlaxoSmithKline (United Kingdom)

Marianne Eybye is an author at Moderna Therapeutics (United States) specializing in vascular biology, hypertension, and medicine.

Top concepts

Publications per year

2003–2024

10

Publications

10

Long-term efficacy and safety of mRNA therapy in two murine models of methylmalonic acidemia

An Ding, Andrea Frassetto, Eric Jacquinet et al. · EBioMedicine · 2019 · 80 citations · Full text

mRNA Therapy Improves Metabolic and Behavioral Abnormalities in a Murine Model of Citrin Deficiency

Jingsong Cao, An Ding, Mikel Galduroz et al. · Molecular Therapy · 2019 · 71 citations · Full text

p38 MAPK Inhibitors Ameliorate Target Organ Damage in Hypertension: Part 1. p38 MAPK-Dependent Endothelial Dysfunction and Hypertension

Haisong Ju, David J. Behm, Sandyha Nerurkar et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 64 citations

Differential Effects of p38 Mitogen-Activated Protein Kinase and Cyclooxygenase 2 Inhibitors in a Model of Cardiovascular Disease

Robert N. Willette, Marianne Eybye, Alan R. Olzinski et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 50 citations

Systemic modified messenger RNA for replacement therapy in alpha 1-antitrypsin deficiency

Ahmad Karadagi, Alex Cavedon, Helen Zemack et al. · Scientific Reports · 2020 · 49 citations · Full text

1–5 of 10